Table 2. Comparison of means of clinical and laboratory variables between the case group (prostatic cancer) and control group.
| Cases Mean (± SD) | Controls Mean (± SD) | p | |
|---|---|---|---|
| Age (years) | 67.00 (± 6.57) | 65.06 (± 5.47) | 0.372 |
| Weight (kg) | 71.56 (± 11.17) | 73.06 (± 11.12) | 0.706 |
| Height (m) | 1.61 (± 0.07) | 1.68 (± 0.07) | 0.017* |
| Body mass index (kg/m2) | 27.30 (± 3.76) | 25.73 (± 3.12) | 0.212 |
| Hip circumference (cm) | 93.25 (± 9.11) | 99.31 (± 9.09) | 0.069 |
| Waist circumference (cm) | 97.18 (± 11.23) | 98.62 (± 11.15) | 0.719 |
| Waist-to-hip ratio | 1.03 (± 0.04) | 0.98 (± 0.05) | 0.004* |
| Systolic pressure (mmHg) | 157 (± 17.84) | 136.88 (± 18.51) | 0.004* |
| Diastolic pressure (mmHg) | 91.50 (± 9.94) | 83.13 (± 8.73) | 0.017* |
| Fasting blood glucose (mg/dl) | 101.6 (± 30.16) | 92.81 (± 13.97) | 0.332 |
| Total cholesterol (mg/dl) | 181.25 (± 36.17) | 208.50 (± 38.46) | 0.048* |
| LDL-c (mg/dl) | 115.93 (± 31.30) | 120.93 (± 42.35) | 0.716 |
| HDL-c (mg/dl) | 36.30 (± 10.75) | 41.69 (± 9.58) | 0.145 |
| Triglycerides (mg/dl) | 148.50 (± 111.90) | 204.50 (± 116.43) | 0.103 |
| Lean body mass (%) | 65.01 (± 2.38) | 65.83 (± 2.21) | 0.324 |
SD = standard deviation; LDL-c = low-density lipoprotein-cholesterol; HDL-c = high-density lipoprotein-cholesterol.
*
statistically significant (p < 0.05).